Who can prescribe GLP-1 for weight loss?

Telehealth can also be an option, but the prescription comes from a licensed treating clinician, not the website or platform. An online questionnaire starts an assessment; it does not guarantee a prescription.

The most useful question is therefore both who can prescribe and who can provide appropriate evaluation and follow-up. That includes checking your health history, explaining the exact medicine being considered, and helping you address side effects or access problems.

Which healthcare professionals can prescribe GLP-1 medicines?

A healthcare license alone does not give every professional authority to prescribe. The clinician's profession, state authorization, scope of practice, and ability to evaluate your needs all matter.

Primary care physicians

Family medicine and internal medicine physicians can evaluate adults for prescription weight-management treatment. You generally do not need to see a specialist just because you are interested in a GLP-1 medicine.

Starting with primary care has a practical advantage: your clinician may already know your medical history, medications, blood pressure, and previous test results. Those details can help them assess whether medication fits your overall care.

However, not every primary care practice manages weight-loss medication. Some clinicians may refer you because they do not offer the follow-up, prescribing expertise, or administrative support the treatment requires. That referral does not, by itself, mean you are ineligible.

When scheduling, ask whether the appointment can include a medical weight-management assessment. This helps the practice allow appropriate time and tell you which records to bring.

Nurse practitioners and physician assistants

Nurse practitioners, or NPs, and physician assistants, or PAs, may prescribe these medicines when authorized under applicable state rules. Their prescribing arrangements differ by state and practice setting, including whether physician collaboration or supervision is required.

An NP or PA may provide weight-management care in a primary care office, specialty clinic, or telehealth service. Their professional title alone does not tell you how much experience they have with obesity treatment.

Ask about the care they provide: Do they evaluate relevant medical conditions? Who handles medication questions? How are follow-up assessments arranged? A clear answer is more useful than assuming that one type of professional always provides better care.

A registered nurse who is not separately authorized as an advanced practice prescriber does not have the same prescribing role as an NP. Similarly, administering an injection and deciding whether to prescribe it are different responsibilities.

Obesity-medicine specialists and endocrinologists

An obesity-medicine specialist focuses on medical weight management. An endocrinologist treats hormone-related and metabolic conditions, including diabetes. Either may be helpful when your history is complex or you need a broader treatment comparison.

Specialist care may be particularly useful if previous treatment has been difficult to tolerate, several medical conditions affect the decision, or you need coordinated care across specialties. A specialist can also help assess options beyond GLP-1 treatment.

You do not need to assume that weight changes mean you have a hormone disorder. Bring the pattern of changes and any accompanying symptoms so the clinician can decide whether further evaluation is appropriate.

Referral requirements vary by practice and insurance plan. A plan may require a primary care referral even when the specialist is otherwise able to prescribe.

Other members of the care team

Dietitians, therapists, exercise professionals, and health coaches can make important contributions to weight-management care. Those credentials alone generally do not authorize someone to prescribe GLP-1 medication.

Pharmacists have a different role: they dispense medicines, check for medication-related problems, and explain the supplied product. Some practice under specific prescribing arrangements, but you should not assume that every pharmacist can independently initiate weight-loss treatment.

The following comparison can help you choose where to begin:

Can a telehealth clinician prescribe GLP-1 for weight loss?

Yes, a clinician providing telehealth care may prescribe when they are appropriately authorized, can perform an adequate assessment, and determine that treatment is clinically appropriate. Telehealth describes how care is delivered. It is not a separate prescribing credential.

State authorization and your location matter

Tell the service where you will physically be during the consultation, including if you are traveling. The clinician's authority to treat you generally depends on the rules that apply where you are located.

Do not assume that a service operating online is available in every state. A platform may serve some locations but not others, and the care pathway may differ according to state requirements.

You can ask for the treating clinician's name and professional credentials, then use the relevant state licensing board to check their license. Medical boards commonly oversee physicians, nursing boards oversee NPs, and the relevant licensing authority for PAs varies by state.

License verification is one useful check. It does not replace asking how the practice evaluates patients or responds when treatment needs change.

Online assessment still requires clinical judgment

A legitimate remote evaluation needs enough information to support a treatment decision. Depending on your circumstances, that may involve medical records, reliable measurements, laboratory testing, a call, or an in-person assessment.

Text-based care can be asynchronous, meaning you and the clinician exchange information at different times. This format may make routine communication more convenient, but it cannot address every medical need.

A clinician may request more information, recommend a different treatment, or explain that remote care is not suitable. These are possible outcomes of an assessment, not failures of the process.

A completed intake is a request for medical evaluation, not confirmation that a prescription will be issued.

If you are comparing online weight-management services, ask how clinical questions reach the treating clinician. Customer support may help with accounts or orders, but medication changes require clinical review.

How the Helimeds pathway works

Through Helimeds, the process begins with an online health-history submission. An affiliated licensed clinician then reviews the information and determines whether further assessment or treatment is appropriate.

A prescription is issued only when clinically appropriate and permitted in your state. If prescribed, medication dispensing and delivery are handled through a pharmacy. Helimeds is the platform, not the manufacturer, dispensing pharmacy, or treating prescriber.

The described consultation pathway uses asynchronous, text-based communication. That does not guarantee that every person can complete care without a call, examination, tests, or referral.

If you choose to start intake, provide complete information rather than trying to predict which answers will lead to approval. The purpose is to identify appropriate care, including when medication is not the right next step.

What determines whether a clinician will prescribe?

Having access to someone who can prescribe does not establish that a particular medicine is suitable for you. The assessment should connect your health needs with the benefits, limitations, and risks of the exact treatment.

Eligibility involves more than a weight measurement

For adult weight management, medicines such as Wegovy and Zepbound are approved for specified populations with obesity, or overweight with a weight-related health condition. The clinician needs to check the exact product's indication and evaluate your circumstances.

Body mass index, or BMI, relates weight to height and is commonly part of that assessment. It does not describe your entire health, and meeting a numerical criterion does not guarantee a prescription.

The clinician may also consider your weight history, related health conditions, eating patterns, physical activity, previous treatment, and goals. Explain what you hope treatment would change, such as mobility, management of a health condition, or difficulty maintaining weight loss.

You do not need to present previous efforts as proof of willpower. A factual account of what you tried, what helped, and what made treatment difficult is more useful for choosing a plan.

Medical history can change the treatment choice

Some findings rule out a particular medicine; others call for closer evaluation or monitoring. Those categories should not be treated as interchangeable.

For example, Wegovy and Zepbound carry boxed warnings about thyroid C-cell tumors. These tumors occurred in animal studies, and whether the medicines cause them in humans is unknown. Both products are contraindicated for people with a personal or family history of medullary thyroid carcinoma, a specific thyroid cancer, or multiple endocrine neoplasia syndrome type 2, also called MEN 2.

That warning does not mean every thyroid condition is a contraindication. Tell the clinician the exact diagnosis, if known, rather than reporting only "thyroid problems." The Wegovy prescribing information and Zepbound prescribing information distinguish these restrictions from other warnings.

Other relevant history includes pancreatic or gallbladder problems, severe digestive symptoms, kidney problems, serious medication allergies, diabetes complications, pregnancy, and breastfeeding. A past diagnosis does not automatically have the same significance for every product.

The medication list needs to be complete

Bring prescription medicines, nonprescription products, vitamins, supplements, and any weight-loss treatment you already use. Include medicines obtained through another telehealth service.

The clinician needs to check for overlapping treatment and interactions. For example, diabetes medicines can affect the risk of low blood sugar, and medicines that slow stomach emptying can raise additional concerns.

Pregnancy planning and contraception also belong in the medication review because advice is product-specific. If you use oral hormonal contraception, specifically ask about tirzepatide's interaction and obtain the current labeled instructions before treatment.

Do not combine, switch, restart, or adjust GLP-1 medicines on your own. If you already take one, provide the exact product, formulation, prescribed dose, last dose date, and any interruption in treatment so the clinician can evaluate the next step.

What exactly is being prescribed?

"GLP-1" is a treatment category, not a complete prescription. Understanding medication names helps you compare options and avoid assuming that similarly described products are interchangeable.

Branded medicines have product-specific identities

Semaglutide acts at receptors for glucagon-like peptide-1, or GLP-1, a hormone involved in appetite and blood sugar regulation. Tirzepatide acts at both GLP-1 and glucose-dependent insulinotropic polypeptide, or GIP, receptors.

Wegovy contains semaglutide, while Zepbound contains tirzepatide. They are distinct products with their own prescribing information. Current Wegovy labeling includes injectable and oral formulations, so asking only for a "GLP-1 shot" may overlook a relevant formulation discussion.

Ozempic also contains semaglutide, and Mounjaro also contains tirzepatide, but those names are not substitutes for Wegovy and Zepbound. Their approved indications differ. Prescribing a product outside its approved indication is called off-label use, which should be explained as such.

Ask which exact brand, route, and indication the clinician is considering. Instructions for an oral product cannot be transferred to an injection, and instructions for one injection device cannot automatically be transferred to another.

Compounded preparations are a separate category

A compounded preparation is not an FDA-approved generic version of Wegovy or Zepbound. Compounded drugs are not FDA-approved, and the FDA does not review their safety, effectiveness, and quality before marketing.

Compounding may have a role in particular circumstances, but a prescription alone does not establish that every preparation is appropriate or permitted. Cost, an added vitamin, or a past shortage does not by itself settle that question.

The FDA's information on unapproved GLP-1 products explains concerns relevant to evaluating these preparations. A study of a branded medicine does not establish equivalent results for a pharmacy's compounded product.

If a compounded treatment is proposed, ask why it is being considered for you, what it contains, which pharmacy will dispense it, and how you will receive product-specific instructions. Keep this discussion separate from a comparison of branded Wegovy and Zepbound.

Helimeds provides separate compounded semaglutide treatment information.

Its compounded tirzepatide treatment information describes that distinct preparation.

A clear prescription includes usable instructions

Before using a prescribed product, you should understand the medication name, route, device, and directions. For a vial, the concentration and measuring device are especially important.

Milligrams describe an amount of medicine, milliliters describe liquid volume, and syringe units describe markings on a particular syringe. They are not interchangeable measurements, and the relationship depends on the exact concentration and device.

Resolve conflicting or unclear instructions with the prescriber or dispensing pharmacist before injecting. A product photograph, vial size, or another person's instructions cannot establish your correct measurement.

Knowing who prescribed the medicine is only part of safe access. You also need to know exactly what the pharmacy supplied and how to use it.

What should you ask before committing to care?

The first prescription is one part of treatment. Comparing follow-up arrangements, costs, and communication can help you choose a service that fits your practical needs.

Find out who handles follow-up and side effects

Ask how progress will be assessed and how you should report symptoms. Follow-up should consider tolerability, nutrition, hydration, relevant health conditions, and your goals, rather than only the number on the scale.

Nausea, vomiting, diarrhea, and constipation can occur with semaglutide or tirzepatide. Severe or persistent symptoms should not be dismissed as proof that treatment is working. These medicines also have important warnings involving the pancreas, gallbladder, dehydration and kidney injury, and serious allergic reactions.

For medication-specific reading, see our guide to tirzepatide side effects.

Seek prompt medical assessment for persistent severe abdominal pain, repeated vomiting, or difficulty keeping fluids down. Trouble breathing, swelling of the face or throat, collapse, or another immediate emergency requires calling 911.

Tell procedural and anesthesia teams if you take one of these medicines because slowed stomach emptying can matter during anesthesia or deep sedation. Obtain product-specific instructions rather than choosing your own medication-withholding plan.

Separate prescribing from insurance approval and fulfillment

A clinician can decide that treatment is appropriate while an insurer decides it is not covered. Those are different decisions. Prior authorization is an insurer's review process, not an additional prescribing credential.

Before paying, ask what the consultation charge covers, whether medication is separate, and how follow-up is billed. For a multi-month offer, distinguish the upfront payment from a monthly equivalent and any recurring charge.

Also clarify what happens if the prescribed product cannot be filled or you cannot tolerate it. Do not assume a refund, replacement, or treatment change is included.

If a clinician declines to prescribe, ask whether the reason is a safety concern, insufficient information, the practice's services, or a need for specialist care. That answer can help you take an appropriate next step without concealing information in another assessment.

How to prepare for your first appointment

You do not need to arrive having chosen a drug. Preparing accurate information gives the clinician a better basis for comparing medication and nonmedication options.

Bring or record:

• Your current height and weight, recent weight changes, and relevant home measurements.
• Diagnosed conditions, previous surgeries, allergies, and available recent test results.
• Your full medication and supplement list, including previous weight-loss prescriptions.
• Past treatment experiences, including benefits, side effects, access problems, and reasons for stopping.
• Relevant family history, especially the exact type of thyroid cancer if one occurred.
• Pregnancy plans, breastfeeding status, contraception, and upcoming procedures.
• Your goals and practical constraints, such as affordability, travel, or difficulty attending appointments.

Useful questions include:

• "Which treatment options fit my health history, and why?"
• "Is the proposed product FDA-approved or compounded?"
• "What additional information or testing do you need?"
• "Which symptoms should I report, and how do I contact the clinical team?"
• "What will follow-up involve, and who makes medication decisions?"
• "What is the plan if treatment is unaffordable or unsuitable?"

Helimeds' important safety information explains platform responsibilities and compounded-medication qualifications; it does not replace your exact product's prescribing information.

If you are transferring care, request records from the previous prescriber and keep the pharmacy label available. A new clinician still needs to evaluate whether continuing treatment is appropriate; an existing prescription does not guarantee a refill.

The right starting point is an assessment, not a promised prescription

Physicians, NPs, and PAs with appropriate state prescribing authority can prescribe GLP-1 medicines for weight loss. Primary care, specialty care, and telehealth can each be reasonable starting points, depending on your health needs and access.

Choose a clinician or service that explains its assessment, identifies the exact treatment, and provides a clear follow-up pathway. If you prefer online care, you can begin a Helimeds intake for licensed-clinician review, with prescribing dependent on clinical appropriateness and state availability. Starting with your existing primary care clinician is equally reasonable.

This article provides general health information and does not replace advice from your licensed healthcare professional.

Frequently asked questions

Do I need diabetes to get a GLP-1 prescription for weight loss?

No. Certain products, including Wegovy and Zepbound, have approved weight-management uses for specified populations who may or may not have diabetes. A clinician must assess the exact product's indication, your health history, and whether treatment is appropriate.

Can my primary care clinician prescribe, or do I need a referral?

A primary care physician, or an appropriately authorized NP or PA, may evaluate and prescribe without a specialist being involved. Whether a particular practice offers that care varies. If specialist assessment is recommended, your insurance plan may have separate referral requirements.

Can a dietitian or health coach prescribe a GLP-1 medicine?

Being a dietitian or health coach does not by itself provide prescribing authority. These professionals can help with nutrition, behavior, and practical support while a licensed prescriber manages medication. If someone holds additional credentials, confirm which professional role authorizes their prescribing.

Is an online eligibility quiz enough to receive a prescription?

A screening quiz can identify information for further review, but it cannot establish a diagnosis or guarantee treatment. An authorized clinician must assess whether prescribing is appropriate and may request records, testing, a call, or an in-person evaluation. Payment or a preliminary eligibility message does not replace that decision.